Page last updated: 2024-10-30

loxoprofen and Psoriasis

loxoprofen has been researched along with Psoriasis in 1 studies

loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sakai, T1
Matsuda-Hirose, H1
Shimada, H1
Sugiura, K1
Hatano, Y1

Other Studies

1 other study available for loxoprofen and Psoriasis

ArticleYear
Generalized pustular psoriasis-like drug eruption manifested by systemic glucocorticosteroid in a patient without IL36RN mutation or an immunological disorder.
    European journal of dermatology : EJD, 2020, Apr-01, Volume: 30, Issue:2

    Topics: Acetaminophen; Amoxicillin; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Anti-Inflammatory Agent

2020